BIG PHARMA EARNINGS WATCH: AMGEN & SANOFI
Nov 5, 2020
Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giants… Read More
© 2026 CSRXP- All Rights Reserved
Updates
CSRXP: GILEAD’S PRICE-GOUGING AMERICAN PUBLIC ON COVID-19 TREATMENT TAXPAYERS PAID TO DEVELOP
Oct 30, 2020
Big Pharma Company Reaping Profit Margin Higher Than 90 Percent on Remdesivir… Read More
SECOND OPINION: BIG PHARMA GAMES THE PATENT SYSTEM TO HIKE PRICES AND BOOST PROFITS — NOT ‘DRIVE INNOVATION’ OR ‘ENHANCE PATIENT ACCESS’
Oct 29, 2020
Drug Companies’ Anti-Competitive Gamesmanship Comes At Tremendous Cost To… Read More
BIG PHARMA EARNINGS WATCH: GLAXOSMITHKLINE
Oct 29, 2020
Brand Name Big Pharma Giant Surpasses Expectations After Hiking Prices A new… Read More
BIG PHARMA EARNINGS WATCH: MERCK, NOVARTIS & PFIZER
Oct 28, 2020
Brand Name Drug Companies Beat Wall Street Expectations After Repeatedly… Read More
ICYMI: BIG PHARMA’S PANDEMIC PRICE HIKES AND PATENT ABUSE UNDERSCORE URGENCY FOR ACTION
Oct 28, 2020
Big Pharma’s Pandemic Price Hikes and Patent Abuse Underscore Urgency for… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Oct 13, 2020
Price Hikes Fuel Q3 Earnings Beat For Brand Name Giant As millions of… Read More
CSRXP: PRESIDENTIAL CAMPAIGNS MUST BACK BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE
Oct 13, 2020
Surrogates for the 2020 Candidates Should Demonstrate Commitment To Lowering… Read More
SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD INCREASE OOP COSTS AND PREMIUMS FOR SENIORS — DO NOTHING TO LOWER RX PRICES
Oct 5, 2020
Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It… Read More
THEY SAID IT: LAWMAKERS EXPOSE BIG PHARMA’S EGREGIOUS PRICE HIKES AND ANTI-COMPETITIVE TACTICS — DEBUNK BLAME GAME AND EXCUSES
Oct 1, 2020
Lawmakers Blast Big Pharma Executives During Two-Day Hearing on… Read More
CSRXP: ASTRAZENECA LEADS BIG PHARMA IN BRAZEN ASSAULT ON CRITICAL 340B PROGRAM, MUST BE HELD ACCOUNTABLE
Oct 1, 2020
Brand Name Drug Company Shirks Requirement to Provide Affordable Medications… Read More
CSRXP COMMENDS LAWMAKERS FOR REFOCUSING CRITICAL ATTENTION ON BIG PHARMA’S EGREGIOUS PRICE HIKES AND PRACTICES
Sep 30, 2020
House Committee on Oversight and Reform to Question Big Pharma Executives… Read More